Millennium Management’s Alder Biopharmaceuticals ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-2,654,751
| Closed | -$50.1M | – | 4889 |
|
|
2019
Q3 | $50.1M | Buy |
2,654,751
+2,300,799
| +650% | +$26.3M | 0.08% | 308 |
|
|
2019
Q2 | $4.17M | Sell |
353,952
-517
| -0.1% | -$6.26K | 0.01% | 1924 |
|
|
2019
Q1 | $4.84M | Sell |
354,469
-122,841
| -26% | -$1.59M | 0.01% | 1790 |
|
|
2018
Q4 | $4.89M | Buy |
477,310
+299,538
| +168% | +$3.83M | 0.01% | 1609 |
|
|
2018
Q3 | $2.96M | Sell |
177,772
-117,958
| -40% | -$2.13M | ﹤0.01% | 2151 |
|
|
2018
Q2 | $4.67M | Buy |
295,730
+121,175
| +69% | +$1.84M | 0.01% | 1856 |
|
|
2018
Q1 | $2.22M | Sell |
174,555
-29,868
| -15% | -$432K | ﹤0.01% | 2252 |
|
|
2017
Q4 | $2.34M | Buy |
+204,423
| New | +$2.28M | ﹤0.01% | 2187 |
|
|
2017
Q3 | – | Sell |
-28,728
| Closed | -$329K | – | 4068 |
|
|
2017
Q2 | $329K | Sell |
28,728
-122,643
| -81% | -$2.27M | ﹤0.01% | 3010 |
|
|
2017
Q1 | $3.15M | Buy |
151,371
+125,059
| +475% | +$2.77M | 0.01% | 1733 |
|
|
2016
Q4 | $547K | Buy |
+26,312
| New | +$684K | ﹤0.01% | 2638 |
|
|
2016
Q1 | – | Sell |
-788,913
| Closed | -$26.1M | – | 3837 |
|
|
2015
Q4 | $26.1M | Sell |
788,913
-716,186
| -48% | -$24.2M | 0.05% | 467 |
|
|
2015
Q3 | $49.3M | Buy |
1,505,099
+32,674
| +2% | +$1.39M | 0.1% | 246 |
|
|
2015
Q2 | $78M | Buy |
1,472,425
+985,135
| +202% | +$35.8M | 0.15% | 139 |
|
|
2015
Q1 | $14.1M | Buy |
487,290
+471,868
| +3,060% | +$12.9M | 0.03% | 852 |
|
|
2014
Q4 | $449K | Sell |
15,422
-68,551
| -82% | -$1.23M | ﹤0.01% | 3058 |
|
|
2014
Q3 | $1.06M | Buy |
+83,973
| New | +$1.27M | ﹤0.01% | 2265 |
|
Millennium Management's ALDR Position: Q4 2019 in Review
Millennium Management sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 2,654,751 shares — an estimated $50.1M sold.
Millennium Management first reported a position in ALDR in Q3 2014 and held it in 17 quarters. The position peaked at $78M in Q2 2015. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.
- Millennium Management reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
- Millennium Management sold 2,654,751 Alder Biopharmaceuticals shares in Q4 2019, an estimated $50.1M.
- Millennium Management first reported a position in Alder Biopharmaceuticals in Q3 2014 and held it in 17 quarters.
- Millennium Management's Alder Biopharmaceuticals position peaked at $78M in Q2 2015.
- 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.
Based on Millennium Management's 13F filing for Q4 2019, filed 14 Feb 2020.